KIT and intrahepatic cholangiocarcinoma: In the colon, the loss of Kit-positive cells (all ICC subtypes) was found to be more than 90% in the middle and distal parts of the colon; the loss of ICC-SMP was almost complete and the loss of ICC-MY was about 50% in the proximal colon [28].